SEC Form 4 · accession 0001179110-16-030454
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maxine Gowen
Director
Period of report
Oct 3, 2016
Accepted (ET)
Oct 5, 2016 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 3, 2016 | P | 4,102 | $2.56 | A | 10,543 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This stock was issued to the reporting person pursuant to her election under the Issuer's director compensation program in lieu of cash.